Cadila Healthcare informs about press release

04 Feb 2021 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated February 4, 2021 titled ‘Zydus announces completion of Phase-I trials of ZY19489-A single dose cure for Malaria in collaboration with MMV’. The contents of the press release give full details. Bring the aforesaid news to the notice of the members of the exchange and the investors at large.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×